Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NMC Health Plc (NMHLY)

NEW YORK, NY / ACCESSWIRE / January 2, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NMC Health Plc (NMHLY) ("NMC" or the Company") (OTC PINK:NMHLY). Investors who purchased NMC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/nmc.

The investigation concerns whether NMC and certain of its officers and/or directors have violated federal securities laws.

On December 17, 2019, Muddy Waters Capital reported "serious doubts about the company's financial statements, including its asset values, cash balance, reported profits, and reported debt levels." Following this news, NMC's stock dropped $11.68 per share, or over 33.7% to close at $23.00 on December 17, 2019.

If you are aware of any facts relating to this investigation, or purchased NMC shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/nmc. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 571796